← All trials
NCT03255915
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2018
- Primary completion
- Sep 30, 2019
- Completion date
- Dec 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oak Crest Institute of ScienceLead sponsor
- Johns Hopkins UniversityCollaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- National Institutes of Health (NIH)Collaborator
- Brown UniversityCollaborator
- University of Texas, GalvestonCollaborator
- University of California, San DiegoCollaborator
- University of Texas, GalvestonOverall official - principal investigator
- Vanderbilt UniversityCollaborator
- University of California, Los AngelesCollaborator
- University of Texas, GalvestonOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.